SCHEMBL24528855

SCHEMBL24528855

CN(C(=O)OC(C)(C)C)C(c1ccc(CN2CCC(O)CC2)cc1)C1CC1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP2D6 P10635 1/20 0.42
HRH3 Q9Y5N1 2/20 0.41
NPC1 O15118 1/20 0.39
KDM4E B2RXH2 5/20 0.39
GAA P10253 1/20 0.39
ACHE P22303 4/20 0.38
BCHE P06276 1/20 0.38
POLB P06746 1/20 0.37
KCNH2 Q12809 1/20 0.36
MGAT2 Q10469 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24528856 0.89 KDM4E (0.36) ALDH1A1MEN1KMT2AHRH3KDM4E
SCHEMBL2238595 0.80 ALDH1A1 (0.47) ALDH1A1RAB9AMEN1KMT2ACYP2D6
SCHEMBL24528859 0.77 AAK1 (0.39) RAB9ACYP2D6NPC1POLB
SCHEMBL6536157 0.77 ALDH1A1 (0.46) ALDH1A1RAB9AMEN1KMT2ACYP2D6
SCHEMBL24528858 0.75 BCL2A1 (0.39) ALDH1A1RAB9ANPC1KDM4E
SCHEMBL24528864 0.74 BCL2A1 (0.43) ALDH1A1RAB9ANPC1
SCHEMBL2236466 0.73 BCHE (0.44) ALDH1A1RAB9AMEN1KMT2ACYP2D6
SCHEMBL24528848 0.73 L3MBTL3 (0.40) ALDH1A1RAB9AMEN1KMT2ANPC1
SCHEMBL5150891 0.71 ACE (0.44) KMT2AHRH3ACHEBCHE
SCHEMBL24881009 0.70 CHRM2 (0.51) ALDH1A1KDM4EPOLBKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116897150-A Novel bifunctional molecules for protein-targeted degradation 安菲斯塔治疗有限公司 2023-10-17 CN disclosed
WO-2022129925-A1 NOVEL BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2022-06-23 WO disclosed